All Stories

  1. PRDM14 promotes malignant phenotype and correlates with poor prognosis in colorectal cancer

    Article • Clinical & Translational Oncology, November 2019, Springer Science + Business Media

    Hisayoshi Igarashi

  2. PRDM14 directly interacts with heat shock proteins HSP90α and glucose-regulated protein 78

    Article • Cancer Science, December 2017, Wiley

    Dr. Chiharu Moriya, Hisayoshi Igarashi

  3. EZH2 expression is a prognostic biomarker in patients with colorectal cancer treated with anti-EGFR therapeutics

    Article • Oncotarget, January 2017, Impact Journals, LLC

    Hisayoshi Igarashi

  4. Cancer stem cells in human gastrointestinal cancer

    Article • Cancer Science, November 2016, Wiley

    Dr. Chiharu Moriya, Hisayoshi Igarashi

  5. The relationship between EZH2 expression and microRNA-31 in colorectal cancer and the role in evolution of the serrated pathway

    Article • Oncotarget, February 2016, Impact Journals, LLC

    Hisayoshi Igarashi

  6. Analysis of the molecular features of rectal carcinoid tumors to identify new biomarkers that predict biological malignancy

    Article • Oncotarget, June 2015, Impact Journals, LLC

    Hisayoshi Igarashi

  7. Tu1917 Analysis of Molecular Features of Rectal Carcinoid Tumors for Identification of New Biomarkers That Predict Biological Malignancy

    Article • Gastroenterology, April 2015, Elsevier

    Hisayoshi Igarashi

  8. Association of MicroRNA-31-5p with Clinical Efficacy of Anti-EGFR Therapy in Patients with Metastatic Colorectal Cancer

    Article • Annals of Surgical Oncology, December 2014, Springer Science + Business Media

    Hisayoshi Igarashi

  9. Sa1921 MicroRNA-31 May Predict Response in Patients With Metastatic Colorectal Cancer Treated With Anti-EGFR Therapy

    Article • Gastroenterology, May 2014, Elsevier

    Hisayoshi Igarashi